Compile Data Set for Download or QSAR
Report error Found 164 Enz. Inhib. hit(s) with all data for entry = 9755
TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486054(US10947210, Compound 06-7A | US10947210, Compound ...)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486277(US10947210, Compound 14-7A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486039(US10947210, Compound 03-8B)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM485969(US10947210, Compound 02-10F)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM485959(US10947210, Compound 02-10A)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM485982(US10947210, Compound 02-8A)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486308(US10947210, Compound 21-5)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486313(US10947210, Compound 23-6C)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486307(US10947210, Compound 20-8)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486312(US10947210, Compound 23-6B)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486305(US10947210, Compound 19-8B)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486309(US10947210, Compound 22-12)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486304(US10947210, Compound 19-8A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486303(US10947210, Compound 18-10B)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486297(US10947210, Compound 17A-8A)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486296(US10947210, Compound 16-7)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486241(US10947210, Compound 13-8D)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486239(US10947210, Compound 13-8C)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486068(US10947210, Compound 06-7C)
Affinity DataEC50: <100nMAssay Description:HCV replicon assay is based on the luciferase reporter cell line (Huh-luc/neo-ET). This reporter cell line is a human liver carcinoma cell line (Huh-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486321(US10947210, Compound 26-7A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486076(US10947210, Compound 06-7F)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486222(US10947210, Compound 12-7B)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486221(US10947210, Compound 12-7A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486200(US10947210, Compound 11-6B)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486194(US10947210, Compound 11-6A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486330(US10947210, Compound 28-8B)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486329(US10947210, Compound 28-8A)
Affinity DataIC50: 100nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486286(US10947210, Compound 15-7)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486285(US10947210, Compound 14-7C)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486282(US10947210, Compound 14-7B)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486246(US10947210, Compound 14-6A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486241(US10947210, Compound 13-8D)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486239(US10947210, Compound 13-8C)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486238(US10947210, Compound 13-8B)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486235(US10947210, Compound 13-8A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486233(US10947210, Compound 13-7D)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486231(US10947210, Compound 13-7C)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486225(US10947210, Compound 13-7B)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486224(US10947210, Compound 13-7A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486223(US10947210, Compound 12-7C)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486306(US10947210, Compound 20-7)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486302(US10947210, Compound 18-10A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486299(US10947210, Compound 17B-8)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486297(US10947210, Compound 17A-8A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486296(US10947210, Compound 16-7)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486294(US10947210, Compound 15-8)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486325(US10947210, Compound 27-9A)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486322(US10947210, Compound 26-7B)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486317(US10947210, Compound 25-5)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Cocrystal Pharma

US Patent
LigandPNGBDBM486315(US10947210, Compound 24-4)
Affinity DataIC50: 550nMAssay Description:The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton X-100, 0.5 uM polyA:U16 substrate, purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

Displayed 1 to 50 (of 164 total ) | Next | Last >>
Jump to: